A molecular prospective provides new insights into implication of PDYN and OPRK1 genes in alcohol dependence

Single nucleotide polymorphisms (SNPs) both in coding and non-coding regions govern gene functions prompting differential vulnerability to diseases, heterogeneous response to pharmaceutical regimes and environmental anomalies. These genetic variations, SNPs, may alter an individual׳s susceptibility for alcohol dependence by remodeling DNA-protein interaction patterns in prodynorphin (PDYN) and the κ-opioid receptor (OPRK1) genes. In order to elaborate the underlying molecular mechanism behind these susceptibility differences we used bioinformatics tools to retrieve differential DNA-protein interactions at PDYN and OPRK1 SNPs significantly associated with alcohol dependence. Our results show allele-specific DNA-protein interactions depicting allele-specific mechanisms implicated in differential regulation of gene expression. Several transcription factors, for instance, VDR, RXR-alpha, NFYA, CTF family, USF-1, USF2, ER, AR and predominantly SP family show an allele-specific binding affinity with PDYN gene; likewise, GATA, TBP, AP-1, USF-2, C/EBPbeta, Cart-1 and ER interact with OPRK1 SNPs on intron 2 in an allele-specific manner. In a nutshell, transition of a single nucleotide may modify differential DNA-protein interactions at OPRK1 and PDYN׳s SNPs, significantly associated with pathology that may lead to altered individual vulnerability for alcohol dependence.

[1]  S. Safe,et al.  Functional synergy between the transcription factor Sp1 and the estrogen receptor. , 1997, Molecular endocrinology.

[2]  K. Machida,et al.  Alcohol Induces RNA Polymerase III-dependent Transcription through c-Jun by Co-regulating TATA-binding Protein (TBP) and Brf1 Expression* , 2010, The Journal of Biological Chemistry.

[3]  S. Southwick,et al.  A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. , 2002, Archives of general psychiatry.

[4]  G. Bakalkin,et al.  Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system , 2012, Front. Mol. Neurosci..

[5]  S. Safe.  Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. , 2001, Vitamins and hormones.

[6]  Kazuya Yamada,et al.  Identification of proteins that interact with NF‐YA , 1999, FEBS letters.

[7]  Donghong Ju,et al.  The CCAAT box-binding transcription factor NF-Y regulates basal expression of human proteasome genes. , 2012, Biochimica et biophysica acta.

[8]  S. V. Deventer,et al.  Cytokine and cytokine receptor polymorphisms in infectious disease , 2000, Intensive Care Medicine.

[9]  R. Tjian,et al.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.

[10]  A. Mackay-Sim,et al.  Schizophrenia, vitamin D, and brain development. , 2004, International review of neurobiology.

[11]  C. Ventura,et al.  Dynorphin B Is an Agonist of Nuclear Opioid Receptors Coupling Nuclear Protein Kinase C Activation to the Transcription of Cardiogenic Genes in GTR1 Embryonic Stem Cells , 2003, Circulation research.

[12]  Remo Rohs,et al.  DNA binding by GATA transcription factor suggests mechanisms of DNA looping and long-range gene regulation. , 2012, Cell reports.

[13]  G. Bakalkin,et al.  Prodynorphin CpG‐SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics , 2011, Addiction biology.

[14]  A. Herz.  Endogenous opioid systems and alcohol addiction , 1997, Psychopharmacology.

[15]  K. Helin,et al.  E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription , 1998, Oncogene.

[16]  Hagit Shatkay,et al.  An integrative scoring system for ranking SNPs by their potential deleterious effects , 2009, Bioinform..

[17]  J. Ott,et al.  Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. , 2004, Pharmacogenetics.

[18]  P. Malloy,et al.  Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. , 2004, Molecular endocrinology.

[19]  W. Hung,et al.  Functional role of VDR in the activation of p27Kip1 by the VDR/Sp1 complex , 2006, Journal of cellular biochemistry.

[20]  G. Bakalkin,et al.  Prodynorphin promoter SNP associated with alcohol dependence forms noncanonical AP-1 binding site that may influence gene expression in human brain , 2011, Brain Research.

[21]  S. Carswell,et al.  Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain , 1994, Brain Research.

[22]  G. Valdez,et al.  Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence. , 2012, Alcohol.

[23]  L. Bierut,et al.  Association of the κ-opioid system with alcohol dependence , 2006, Molecular Psychiatry.

[24]  P. Brachet,et al.  1,25‐dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro , 1998 .

[25]  Vip Viprakasit,et al.  A Regulatory SNP Causes a Human Genetic Disease by Creating a New Transcriptional Promoter , 2006, Science.

[26]  Britt Mellström,et al.  DREAM is a Ca2+-regulated transcriptional repressor , 1999, Nature.

[27]  S. Cichon,et al.  Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate , 2011, The Pharmacogenomics Journal.

[28]  S. Orkin,et al.  Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1 , 1991, Nature.

[29]  Elaine H. Zackai,et al.  Identification of a Mutation in a GATA Binding Site of the Platelet Glycoprotein Ibβ Promoter Resulting in the Bernard-Soulier Syndrome* , 1996, The Journal of Biological Chemistry.

[30]  L. Terenius,et al.  Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems. , 1994, Alcoholism, clinical and experimental research.

[31]  G. Wray,et al.  Multiple Functional Variants in cis Modulate PDYN Expression. , 2010, Molecular biology and evolution.

[32]  T. Miyata,et al.  Isolation and structural organization of the human preproenkephalin B gene , 1982, Nature.

[33]  Shwu‐Yuan Wu,et al.  Binding Site Specificity and Factor Redundancy in Activator Protein-1-driven Human Papillomavirus Chromatin-dependent Transcription* , 2011, The Journal of Biological Chemistry.

[34]  C. Mueller,et al.  GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. , 1994, The Journal of biological chemistry.

[35]  L. Guarente,et al.  A cDNA encoding a human CCAAT-binding protein cloned by functional complementation in yeast. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Chih-Cheng Chen,et al.  VarioWatch: providing large-scale and comprehensive annotations on human genomic variants in the next generation sequencing era , 2012, Nucleic Acids Res..

[37]  C. Klinge.  Estrogen receptor interaction with estrogen response elements. , 2001, Nucleic acids research.

[38]  Y Zhu,et al.  E2F6 negatively regulates ultraviolet-induced apoptosis via modulation of BRCA1 , 2007, Cell Death and Differentiation.

[39]  C. Schwarzer,et al.  Possible Role of Dynorphins in Alzheimer's Disease and Age-Related Cognitive Deficits , 2013, Neurodegenerative Diseases.

[40]  S. Simmons,et al.  Nkx3.1 binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells. , 2006, The Biochemical journal.

[41]  Jonghwan Kim,et al.  Mapping the chromosomal targets of STAT1 by Sequence Tag Analysis of Genomic Enrichment (STAGE). , 2007, Genome research.

[42]  B. K. Chen,et al.  Functional interaction between c-Jun and promoter factor Sp1 in epidermal growth factor-induced gene expression of human 12(S)-lipoxygenase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Mori,et al.  Tat-binding protein-1 (TBP-1), an ATPase of 19S regulatory particles of the 26S proteasome, enhances androgen receptor function in cooperation with TBP-1-interacting protein/Hop2. , 2009, Endocrinology.

[44]  J. Kraus,et al.  Regulation of μ-Opioid Receptor Gene Transcription by Interleukin-4 and Influence of an Allelic Variation within a STAT6 Transcription Factor Binding Site* , 2001, The Journal of Biological Chemistry.

[45]  P. Raychaudhuri,et al.  Association of p107 with Sp1: genetically separable regions of p107 are involved in regulation of E2F- and Sp1-dependent transcription , 1995, Molecular and cellular biology.

[46]  B. Hoebel,et al.  Effect of ethanol on hypothalamic opioid peptides, enkephalin, and dynorphin: relationship with circulating triglycerides. , 2007, Alcoholism, clinical and experimental research.

[47]  J. Ott,et al.  A Functional Haplotype Implicated in Vulnerability to Develop Cocaine Dependence is Associated with Reduced PDYN Expression in Human Brain , 2009, Neuropsychopharmacology.

[48]  D. Eyles.  Vitamin D and brain development , 2016 .

[49]  M. Schweizer,et al.  Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1. , 1999, Gene.

[50]  A. Mackay-Sim,et al.  Vitamin d3 and brain development , 2003, Neuroscience.

[51]  Xin Chen,et al.  TRANSFAC: an integrated system for gene expression regulation , 2000, Nucleic Acids Res..

[52]  H. Smeets,et al.  A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. , 2007, Alcoholism, clinical and experimental research.

[53]  G. Suske.  The Sp-family of transcription factors. , 1999, Gene.

[54]  J. Kraus,et al.  The Role of Nuclear Factor κB in Tumor Necrosis Factor-Regulated Transcription of the Human μ-Opioid Receptor Gene , 2003 .

[55]  J. Pankow,et al.  Associations of SNPs in ADIPOQ and Subclinical Cardiovascular Disease in the Multi‐Ethnic Study of Atherosclerosis (MESA) , 2011, Obesity.

[56]  V. Chefer,et al.  Modulation of the Behavioral and Neurochemical Effects of Psychostimulants by κ‐Opioid Receptor Systems , 2001, Annals of the New York Academy of Sciences.

[57]  D. Theobald,et al.  An essential role for ΔFosB in the nucleus accumbens in morphine action , 2006, Nature Neuroscience.

[58]  A. Mortazavi,et al.  Genome-Wide Mapping of in Vivo Protein-DNA Interactions , 2007, Science.

[59]  Rolf Ohlsson,et al.  Chromosome crosstalk in three dimensions , 2009, Nature.

[60]  H. Zakon.  The effects of steroid hormones on electrical activity of excitable cells , 1998, Trends in Neurosciences.

[61]  C. Wijmenga,et al.  Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23. , 2010, American journal of human genetics.

[62]  M. Gottesman,et al.  Sensitive measurement of single-nucleotide polymorphism-induced changes of RNA conformation: application to disease studies , 2012, Nucleic acids research.

[63]  Y. Tsao,et al.  Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability , 2007, Nucleic acids research.

[64]  A. Routtenberg,et al.  Gene expression of the transcription factor NF-kappa B in hippocampus: regulation by synaptic activity. , 1996, Brain research. Molecular brain research.

[65]  J. Franck,et al.  The selective κ-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat , 2001, Behavioural Brain Research.

[66]  L. Terenius,et al.  The Leu-enkephalin-encoding sequence DNA-binding factor (LEF) is the transcription factor YY1. , 1997, Biochemical and biophysical research communications.

[67]  Ishani Deb,et al.  Single‐nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu‐opioid receptor and may contribute to the genetic risk for addiction , 2010, Journal of neurochemistry.

[68]  Aleksey Y. Ogurtsov,et al.  Expansion of the human μ-opioid receptor gene architecture: novel functional variants , 2008, Human molecular genetics.

[69]  E. Butelman,et al.  Effect of the endogenous κ opioid agonist dynorphin A(1–17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice , 2004, Psychopharmacology.

[70]  D. Agard,et al.  Estrogen receptor pathways to AP-1 , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[71]  Jan Komorowski,et al.  Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders. , 2008, Genome research.